Skip to content
Teethgrinder – Lifestyle
Author:
Vertero Therapeutics, Inc.
Vertero Completes Patient Enrollment in Phase 1b Clinical Study of VT-5006 – an Investigational Treatment for Parkinson’s Disease
October 27, 2026
Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease
May 19, 2026